Not Yet Recruiting
Primary Plasma Cell Leukemia: a Prospective Phase 2 Study Incorporating Daratumumab to Chemotherapy and Stem Cell Transplantation
NCT05054478
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
Not specified